ArticleAntimicrobial agents and chemotherapy2003
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
Article in Antimicrobial agents and chemotherapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 82 citations in OpenAlex.
- Review
- Amphotericin B ResistantInfectious diseases & clinical microbiology · 2024Article
- Epidemiology and antifungal susceptibilities of clinically isolatedEpidemiology and infection · 2023Article
- A 20-Year Antifungal Susceptibility Surveillance (From 1999 to 2019) forFrontiers in microbiology · 2021Article
- Article
- Isolation and Characterization of Clinical Triazole ResistanceIranian journal of public health · 2018Article
- Article
- Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.Mycopathologia · 2016Article
- In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.Antimicrobial agents and chemotherapy · 2015Article
- Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates.Journal of clinical and diagnostic research : JCDR · 2015Article
- In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi.Antimicrobial agents and chemotherapy · 2013Article
- Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.Infection · 2012Article
- Invasive aspergillosis: resistance to antifungal drugs.Mycopathologia · 2012Review
- Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus.FEMS microbiology letters · 2012Article
- Cryptic species and azole resistance in the Aspergillus niger complex.Antimicrobial agents and chemotherapy · 2011Article
- Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.Journal of clinical microbiology · 2011Article
- Antifungal drug resistance of oral fungi.Odontology · 2010Review
- Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.Emerging infectious diseases · 2009Article
- Efflux-mediated antifungal drug resistance.Clinical microbiology reviews · 2009Review
- In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species.Journal of clinical microbiology · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of the present study was to identify retrospectively trends in the species distributions and the susceptibility patterns of Aspergillus species causing fungal infections in Spanish medical centers from 2000 to 2002. The susceptibilities of 338 isolates to amphotericin B, itraconazole, and voriconazole were tested. Aspergillus fumigatus was the most common species (54.7%), followed by Aspergillus terreus (14.8%) and Aspergillus flavus (13.9%). Non-A. fumigatus species were encountered in 45.3% of the samples studied. The majority of Aspergillus isolates were obtained from respiratory tract specimens, followed by ear and skin samples. The geometric mean (GM) MIC of amphotericin B was 0.56 micro g/ml, and the amphotericin B MIC was >2 micro g/ml for 16 isolates (4.7%). Nine of them were A. terreus. The GM MIC of itraconazole was 0.37, and the itraconazole MIC was >4 micro g/ml for 12 (3.5%) isolates. The voriconazole MICs were also high for 8 of the 12 strains for which itraconazole MICs were high (voriconazole MIC range, 2 to 8 micro g/ml).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.